Summary:
- The article discusses a study that found the FDA-approved genetics algorithm failed to accurately predict opioid abuse risk. The algorithm was meant to help doctors identify patients at higher risk of opioid addiction, but the study showed it had poor predictive power.
- Researchers analyzed data from over 5,000 patients and found the algorithm only correctly identified 7% of those who went on to develop opioid use disorder. This raises concerns about the algorithm's reliability and potential for misuse in clinical settings.
- The article highlights the need for more rigorous testing and validation of algorithms used in healthcare decision-making, especially when they involve sensitive and high-stakes issues like opioid addiction.